|
|
||||||||
Department of Nuclear Medicine/PET, VA Western New York Healthcare System, Buffalo, New York
Correspondence: For correspondence or reprints contact: Syed Sajid Husain, 3495 Bailey Ave., Buffalo, NY 14215. E-mail: syed.husain{at}med.va.gov
ABSTRACT
Is there an ideal myocardial perfusion imaging protocol? In order to answer this question and choose a protocol for clinical use, one must understand the characteristics of the available radiopharmaceuticals, the protocol variables, and the advantages and disadvantages of each. After reading this article, the technologist should be able to list the ideal characteristics of a myocardial perfusion imaging agent, describe and compare the characteristics of myocardial perfusion imaging agents, discuss the relationship between coronary blood flow and myocardial uptake of various tracers, describe imaging protocols, and discuss the advantages and disadvantages of each protocol.
Key Words: myocardial perfusion imaging; tracer kinetics; coronary blood flow; myocardial uptake; 201Tl; 99mTc
This article has been cited by other articles:
![]() |
A. L. Baggish and C. A. Boucher Radiopharmaceutical Agents for Myocardial Perfusion Imaging Circulation, October 14, 2008; 118(16): 1668 - 1674. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE JOURNAL OF NUCLEAR MEDICINE | JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY |